Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Amortizatization of Intangibles (2020 - 2021)

Historic Amortizatization of Intangibles for Apellis Pharmaceuticals (APLS) over the last 2 years, with Q4 2021 value amounting to $3000.0.

  • Apellis Pharmaceuticals' Amortizatization of Intangibles fell 9997.97% to $3000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $113000.0, marking a year-over-year decrease of 9924.58%. This contributed to the annual value of $113000.0 for FY2021, which is 9924.58% down from last year.
  • Latest data reveals that Apellis Pharmaceuticals reported Amortizatization of Intangibles of $3000.0 as of Q4 2021, which was down 9997.97% from -$8000.0 recorded in Q3 2021.
  • Apellis Pharmaceuticals' 5-year Amortizatization of Intangibles high stood at $14.8 million for Q4 2020, and its period low was -$242000.0 during Q2 2021.